Development of a risk score for intramyocardial hemorrhage in elderly STEMI patients after primary PCI: a

Rui Wang1, Cuijun Hao1, Jiaqi Liu2

  • 1Department of Cardiology, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China.

Insights

Intramyocardial hemorrhage (IMH) is common in elderly STEMI patients post-PCI. A new risk score (IMH-RS) effectively predicts IMH risk using factors like renal function and coronary disease, aiding early stratification.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Diagnostic Imaging

Background:

  • Intramyocardial hemorrhage (IMH) is a significant complication in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI).
  • Predicting IMH is crucial for risk stratification and guiding management in elderly STEMI patients.

Purpose of the Study:

  • To identify independent risk factors for IMH in elderly STEMI patients post-primary PCI.
  • To develop and validate a clinical risk score (IMH-RS) for predicting IMH in this patient population.

Main Methods:

  • Retrospective observational study of 232 elderly STEMI patients undergoing primary PCI.
  • Cardiac magnetic resonance (CMR) imaging used to classify patients into IMH and non-IMH groups.
  • Multivariate logistic regression analysis to identify independent predictors; development and internal validation of the IMH-RS.

Main Results:

  • The incidence of IMH was 33.2%.
  • Independent predictors identified: renal insufficiency, left anterior descending artery involvement, door-to-balloon time >45 min, triple-vessel disease, elevated B-type natriuretic peptide, and reduced left ventricular ejection fraction.
  • The developed IMH-RS demonstrated good discrimination (AUC=0.82) and effectively stratified patients into low, intermediate, and high-risk groups.

Conclusions:

  • IMH is prevalent in elderly STEMI patients after primary PCI and associated with specific clinical and procedural factors.
  • The IMH-RS is a novel, practical bedside tool for early risk stratification, integrating multiple risk factors.
  • This score can guide targeted management strategies to mitigate microvascular injury in high-risk patients.
Abstract

Related Concept Videos